Increased lysophosphatidylcholine content in lesional psoriatic skin
- 1 September 1995
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 133 (3) , 398-402
- https://doi.org/10.1111/j.1365-2133.1995.tb02667.x
Abstract
Various cell stimuli occur via activation of phospholipase A2, which hydrolyses polyunsaturated fatty acids from the sn-2 position of membrane phospholipids, resulting in the formation of polyunsaturated fatty acids and lysophospholipids. The level of lysophospholipids is determined by the balance between phospholipase A2 activity and the rate of catabolism of the lysophospholipids. One of the lysophospholipid classes, lysophosphatidylcholine, has been shown to stimulate certain leucocyte activities which are of importance for the induction and maintenance of inflammation. In addition, it has been demonstrated that phospholipase A2 activity is increased in psoriatic skin. In the present study, we analysed the levels of lysophosphatidylcholine, by thin layer chromatography, in lesional psoriatic skin, uninvolved psoriatic skin and normal skin. The lysophosphatidylcholine content, expressed as mumol lysophosphatidylcholine/mumol phosphatidylcholine, was 1.55, 0.21 and 0.12% in lesional psoriatic skin, uninvolved psoriatic skin and normal skin, respectively. The level of lysophosphatidylcholine was significantly elevated in lesional compared with uninvolved psoriatic skin (P = 0.004) and normal skin (P = 0.002). The increased lysophosphatidylcholine levels in psoriatic skin indicate that the phospholipase A2 activation is not accompanied by a corresponding increase in the activity of enzymes catabolizing lysoPC. If present in biologically active concentrations, lysophosphatidylcholine may contribute to the induction and maintenance of the inflammatory and immunological processes occurring in lesional psoriatic skin.Keywords
This publication has 10 references indexed in Scilit:
- Lysophosphatidylcholine: a chemoattractant to human T lymphocytesArchives of Dermatological Research, 1994
- Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells.Journal of Clinical Investigation, 1992
- Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C.Proceedings of the National Academy of Sciences, 1992
- Activation of a keratinocyte phospholipase A2 by bradykinin and 4β‐phorbol 12‐myristate 13‐acetateEuropean Journal of Biochemistry, 1991
- Lysophosphatidylcholine induces mast cell secretion and protein kinase C activationJournal of Allergy and Clinical Immunology, 1991
- Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.Proceedings of the National Academy of Sciences, 1988
- Heterogeneous distribution of lipoxygenase products in psoriatic skin lesionsArchives of Dermatological Research, 1987
- Characterization and activity of phospholipase A2 in normal human epidermis and in lesion-free epidermis of patients with psoriasis or eczemaBritish Journal of Dermatology, 1985
- Amphipathic metabolites and membrane dysfunction in ischemic myocardium.Circulation Research, 1984
- Phospholipase A activity in the skin. Modulators of arachidonic acid release from phosphatidylcholineBiochemical Journal, 1979